A Risk Assessment Tool to Increase Statin Use Among High Risk Cancer Survivors: Development and Pilot Testing
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 49
- 试验地点
- 1
- 主要终点
- number of patients who initiated statins after the office visit
研究概览
简要总结
The purpose of this study is to collect initial data on what survivors of childhood, adolescent, and young adult cancer think of how information about statins is communicated. Statins are medications that lower cholesterol. The results of this study will be used to improve the communication about statins. This is to aid patients and their providers in making health care decisions together, also known as shared decision making.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 25 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •English speaking
- •A personal history of cancer, tumor, or a related illness
- •Followed in the Adult Long Term Follow Up Program
- •Received ≥ 2000 cGy radiation to the heart/chest
- •≥Ten years post-radiation therapy to the heart/chest
- •Age ≥ 25 years old
排除标准
- •Evidence of active progression of disease or recurrence
- •Neurocognitive deficits that impair ability to give informed consent
- •Current use of a statin
- •Diagnosis of another primary cancer for which the patient is currently undergoing radiation therapy chemotherapy, or bone marrow transplant
- •Diagnosis of CVD with or without current statin use
结局指标
主要结局
number of patients who initiated statins after the office visit
时间窗: 1 year
This data will allow validation of the adapted tool in the cancer survivor population. Acceptability will be estimated using the tool describe which will be transformed to a 0 to 100 scale and summarized separately in the two populations using means and standard deviations.These preliminary statistics in both populations (intervention and usual care) will be utilized to design a future larger scale study powered to detect a difference between the two groups.
次要结局
未报告次要终点